We also observed significantly increased Srx, PrxsI, PrxII, and PrxIII expression via quantitative real-time polymerase chain reaction (qRT-PCR) in CD133+ CSCs freshly isolated from colon cancer patients (Fig. 2D). This evidence concerns the gene SRXN1 and malignant colon neoplasm.